FIFTH AMENDMENT TO PATENT LICENSE AGREEMENTPatent License Agreement • August 7th, 2017 • Kura Oncology, Inc. • Pharmaceutical preparations
This FIFTH AMENDMENT TO PATENT LICENSE AGREEMENT (“Amendment”) is entered into as of May 24, 2017 (the “Amendment Effective Date”) by and between Kura Oncology, Inc. (“Licensee”) having the address set forth in Article 12 of the Agreement (as defined below), and the Regents of the University of Michigan, a constitutional corporation of the state of Michigan (“Michigan”).
